Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 1997

View Archived Issues

French researcher discloses preventive effects of tryptamine derivatives

New approach to obesity gene research at Lilly

New topoisomerase I inhibitors synthesized at Rutgers

Dual TNF/PDE IV inhibitors described by Chiroscience

Allergan claims retinoid-like compounds

NO donors claimed by Searle for cardiovascular applications

MRC scientists investigate role of somatostatin receptors in the CNS

French investigators announce success of gene therapy for CF

Millennium/Roche obesity collaboration results in another significant discovery

AutoImmune initiates clinical trials in transplant rejection

Gene therapy for AIDS to enter clinical testing in U.S.

Betafectin clinical update

Chemopreventive properties of resveratrol publicized

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Bio-Technology General's OxSODrol tested for safety and efficacy

Schering-Plough selects Corvas thrombin inhibitor for development

OXIS files IND for BXT-51072

Biopool enters option agreement for assay technology

Cell Genesys signs cancer gene therapy R&D collaborations

NeXstar reveals new oligonucleotide synthesis method

Palatin, Nihon Medi-Physics forge licensing agreement for diagnostics

Biometric Imaging and Immucor sign marketing agreement

Ventus progressing well in phase III

TLC ELL-12 in toxicology testing

Viracept expanded access program broadened

Update on Cypros' CPC-211 and CPC-111

Positive phase III results reported for SCF

The Liposome Company's Abelcet receives marketing approval in 14th country

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...